More Americans Taking Doctors' Advice On OTCs

22 September 1996

Over half of US patients say they used an over-the-counter drug on a doctor's recommendation, says a new study from Scott-Levin Healthcare consultant; in 1994 the figure was 37%. Almost 90% of consumers say they try an OTC remedy before seeing a doctor, said company chief executive Joy Scott, noting that the OTC marketplace is volatile, and changes in it are altering the way consumers relate to the health care system.

The report notes that over 40% of doctors say they have recommended more OTCs in the past 12 months. This relates to an increased number of prescription-to-OTC switches, among other reasons. Other evidence of the growing influence of OTCs noted in the study include:

- OTC samples given to patients by doctors play an important role, with 35% of consumers saying they received them in the past year. Over half said they would buy the same product on their own;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight